ALB and neoplasm: Furthermore, administration of IR‐TAM@Alb nanoparticles did not result in a significant alteration in the body weight of MB49 tumor‐bearing mice when compared to the Vehicle group, suggesting that IR‐TAM@Alb exhibited desirable biocompatibility in vivo (Figure 5E).